Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of serbian patients with primary and secondary antiphospholipid syndrome

Israel Medical Association Journal

Volumn 16, Issue 3, 2014, Pages 162-167

  Djokovic, Aleksandra ^a   Stojanovich, Ljudmila ^a   Kontic, Milica ^b   Stanisavljevic, Natasa ^a   Radovanovic, Slavica ^a   Marisavljevic, Dragomir ^a  

^a University Medical Center Bezanijska Kosa   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Antiphospholipid antibodies (aPL); Cardiac manifestations; National cohort study; Systemic lupus erythematosus (SLE)

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGE; ANGINA PECTORIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CARDIOMYOPATHY; DISEASE ASSOCIATION; ENDOCARDITIS; FEMALE; HEART DISEASE; HEART INFARCTION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VASCULAR LESION;

ADULT; AGE FACTORS; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SERBIA;

EID: 84897934733     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63.
2. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000; 15: 145-51.
3. Miyakis S, Lockshin MD, Atsumi, T et al. International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
4. Ames PR, Margarita A, Delgado Alves J, et al. Anticardiolipin antibody levels and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies. Lupus 2002; 11: 208-14.
5. Courdray N, de Zuttere D, Bletry O, et al. M mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndrome. Br Heart J 1995; 74: 531-5.
6. Stojanovich L. Autonomic dysfunction in autoimmune rheumatic disease. Autoimmun Rev 2009; 8 (7): 569-72.
7. Leung WH, Wong KL, Lau CP, et al. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990; 89: 411-19.
8. Jara LJ, Medina G, Vera-Lastra O, et al. Atherosclerosis and antiphospholipid syndrome. Clin Rev Allergy Immunol 2003; 25: 79-87.
9. Cervera R. Recent advances in antiphospholipid antibody-related valvulopathies. J Autoimmun 2000; 15: 123-5.
10. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
11. Bombardieri C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
12. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633.
13. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/ Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
14. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet 2010; 376: 1498-509.
15. Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 2005; 93: 1147-52.
16. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924; 33: 701-37.
17. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335: 1424-30.
18. Hojnik M, George J, Ziporen L, et al. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996; 93: 1579-87.
19. Nihoyannopoulos P, Gomez PM, Joshi J, et al. Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies. Circulation 1990; 82: 369-75.
20. Khamashta MA, Cervera R, Asherson RA, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1541-4.
21. Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992; 20: 1127-34.
22. Farzaneh-Far A, Roman M, Lockshin M, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 2006; 54 (12): 3918-25.
23. Cabiedes J, Cabral AR, Alarcon-Segovia D. Clinical manifestation of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with beta2GPI than with other antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
24. Shoenfeld Y, Krause I, Kvapil F, et al. Prevalence and clinical associations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome. J Clin Immunol 2003; 23: 377-83.
25. Zinger H, Sherer Y, Shoenfeld Y. Atherosclerosis in autoimmune rheumatic diseases -mechanisms and clinical findings. Clin Rev Allergy Immunol 2009; 37 (1): 20-8.